Moreover, epidermal growth factor (EGF) has also been reported to inhibit tumor cell proliferation in esophageal cancers via STAT1 activation, paralleling the signaling of IFN-γ that induces apoptosis in esophageal tumor cells. Here, IFNG is linked to neoplasm.